Recipient Vessels for Free Tissue Flaps in Advanced Oncologic Defects of the Midface and Scalp
1 other identifier
interventional
32
1 country
1
Brief Summary
The goal of this clinical trial is to compare the postoperative outcomes based on superficial temporal versus cervical recipient vessels for midface and scalp advanced oncologic defects using free tissue flap for reconstruction. The main question it aims to answer is: • Which recipient vessel is most suitable for performing microanastomosis using free flaps for advanced midface and scalp oncologic defect. Participants will be undergo resection of advanced malignant tumors of the midface and scalp with subsequent oncological reconstruction using free tissue flap. Researchers will compare two groups where those in whom superficial temporal vessels will be used as the recipient vessels (group A) and those in whom cervical vessels will be used as the recipient vessels (group B) to see if there is a recipient vessel who is most suitable for performing microanastomosis using free flaps for advanced midface and scalp oncologic defect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedFirst Submitted
Initial submission to the registry
February 18, 2023
CompletedFirst Posted
Study publicly available on registry
March 1, 2023
CompletedMarch 7, 2023
March 1, 2023
4.1 years
February 18, 2023
March 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To compare the overall flap survival rate after the microanastomosis
Adequate perfusion of the free tissue flap was assessed using Doppler flowmetry, flap bleeding time after puncture, color, texture and turgor. Both venous and arterial thrombosis were evaluated by these methods in order to detect whether there was any evidence of low or absence of vascular perfusion of the flap.
Participants were assessed twice a day for the first 10 days after the intervention and then weekly for 4 weeks.
Study Arms (2)
Superficial temporal recipient vessels (group A)
EXPERIMENTALParticipants in whom superficial temporal vessels were used as the recipient vessels.
Cervical recipient vessels (group B)
ACTIVE COMPARATORParticipants in whom cervical vessels were used as the recipient vessels.
Interventions
Free tissue flaps harvesting and microanastomosis were performed by the same surgeon and in a similar way in both group. Postoperative course, and complications were recorded and analyzed.
Eligibility Criteria
You may qualify if:
- Patients submitted to subtotal, total, or extensive radical oncologic maxillectomy, or advanced scalp oncologic defect
- Complete medical records for at least 30 days after the intervention
- Patients eligible for microanastomosis in both cervical and superficial temporal recipient vessels
You may not qualify if:
- Pregnancy or breastfeeding;
- Serious diseases (sepsis, renal and hepatic failure, severe cardiovascular diseases, chronic obstructive pulmonary disease);
- Patients with HIV (human immunodeficiency virus) with or without AIDS (acquired immunodeficiency syndrome);
- Patients with synchronous malignant neoplasms of the upper airway-digestive tract;
- Patients who died within a period of less than 30 days or who were lost to follow-up for the same period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brazilian National Cancer Institute
Rio de Janeiro, 20230130, Brazil
Related Publications (4)
Awwad L, Obed D, Vogt PM, Kaltenborn A, Koenneker S. Superficial Temporal Recipient Vessels for Craniofacial Microvascular Free-Flaps. J Craniofac Surg. 2022 Sep 1;33(6):e652-e657. doi: 10.1097/SCS.0000000000008768. Epub 2022 Jul 22.
PMID: 35864586RESULTMata Ribeiro L, Tsao CK, Hung YL, Chu CH, Lin LC, Lin MH, Peng C, Cheong DC, Hung SY, Liao CT. Venous Size Discrepancy Is a Critical Factor When Using Superficial Temporal Vessels as Recipient Vessels for Free Flaps. J Reconstr Microsurg. 2022 Oct;38(8):654-663. doi: 10.1055/s-0042-1743165. Epub 2022 Feb 25.
PMID: 35213928RESULTSudirman SR, Shih HS, Chen JC, Feng KM, Jeng SF. Superficial temporal vessels, both anterograde and retrograde limbs, are viable recipient vessels for recurrent head and neck reconstruction in patients with frozen neck. Head Neck. 2019 Oct;41(10):3618-3623. doi: 10.1002/hed.25886. Epub 2019 Jul 26.
PMID: 31347733RESULTMattine S, Payne KFB. The evolving role of the superficial temporal vessels as anastomotic recipients in challenging microvascular reconstruction of the upper two-thirds of the face. J Plast Reconstr Aesthet Surg. 2022 Sep;75(9):3330-3339. doi: 10.1016/j.bjps.2022.04.089. Epub 2022 May 2.
PMID: 35710778RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bruno A Sousa, MD
Brazilian National Cancer Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The care provider knows the surgical intervention and the randomized participant doesn´t know the recipient vessel performed
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 18, 2023
First Posted
March 1, 2023
Study Start
April 1, 2018
Primary Completion
April 30, 2022
Study Completion
June 30, 2022
Last Updated
March 7, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share